Clinical trial
Modulation of the Surgical Inflammatory Response by Etoricoxib: Peripheral Versus Central
NCT00746720 is registered in ClinicalTrials.gov with University of Erlangen-Nürnberg Medical School as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Modulation of the Surgical Inflammatory Response by Etoricoxib: Peripheral Versus Central
- Lead sponsor
- University of Erlangen-Nürnberg Medical School
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- May 31, 2006
- Completion date
- December 31, 2010
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.